Effects of obesity and weight loss on airway physiology and inflammation in asthma☆
Introduction
Over the past 10 years, unequivocal evidence has emerged implicating obesity as a major risk factor for asthma. The reasons for this are still far from clear. During the same time period, intensive research efforts directed towards understanding the effects of obesity on human physiology and immunology have taken place, many of these studies are pertinent to our understanding of asthma in obesity. At the same time, data are emerging which suggest that asthma in obesity is not a single phenotype, but is likely to occur through the interaction of mechanical factors and altered immunology either interacting with pre-existing airway disease, or leading to de novo disease.
The purpose of this article is to briefly review the epidemiological data linking asthma and obesity, with a particular emphasis on the implications of this data for the phenotype of asthma in obesity. We will discuss the effects of obesity and weight loss on airway inflammation and physiology relevant to asthma, and discuss the relevance of these findings for our current understanding of asthma in obesity.
The prevalence of obesity has been increasing throughout the developed world, as has been discussed in detail in other articles in this issue.
A large number of publications have reported that obesity is a risk factor for asthma. This has been reported in adults and children, men and women, and publications have come from around the world suggesting that this is consistent across diverse ethnic populations [1], [2], [3], [4], [5], [6]. For example, one widely quoted meta-analysis published by Beuther and Sutherland in 2007 pooled data from seven studies, involving over 300 000 subjects: compared with normal weight, overweight and obesity status (body mass index, BMI ≥ 25 kg/m2) increased the odds of incident asthma by 1.51 [1]. There was also a dose–response effect of elevated BMI on the incidence of asthma: there was a higher risk of developing incident asthma for subjects who were obese over and above the risk for those that were merely overweight. Some studies have reported an increased risk for the development of asthma in obese women but not men [7]; in the meta-analysis by Beuther & Sutherland, the risk was elevated for both men and women, with an odds ratio of 1.46 in men, and 1.68 in women. While women may have a slightly higher risk of developing asthma in the setting of obesity, obesity is a risk factor for asthma in both men and women, indeed it is a risk factor for asthma among all demographic groups.
Most studies have reported on the overall risk of developing asthma in the setting of obesity. Some studies have reported on the risk of developing asthma in atopic versus non-atopic individuals (Table 1). An example of this was a cross-sectional survey study of 86 000 adult Canadians asthma published by Chen et al. [3]. These authors reported that non-allergic individuals had a higher risk of asthma in the setting of obesity than allergic individuals: the adjusted odds ratio of having asthma in the setting of obesity was 2.53 in non-allergic and only 1.57 in allergic women. Atopic status similarly affected the risk of asthma in the setting of obesity for men, though the overall risk of reporting asthma in the setting of obesity was a little lower for both allergic and non-allergic men. The preponderance of publications supports the observation that obesity is a risk for asthma particularly among the non-allergic adults, and no publications have reported the reverse [8], [9], [10], [11], [12].
Section snippets
Airway inflammation in obesity and asthma
Typical early onset allergic asthma is characterized by airway eosinophilia. Eosinophils release inflammatory mediators such as eosinophil cationic protein which cause airway inflammation in asthma [13]. As reports of the increased rates of asthma in obesity were emerging, investigators started to report on the effects of obesity on markers of cellular inflammation. It seemed logical to assume that if obesity was a risk factor for asthma, it was likely increasing allergic inflammation in the
Conclusions
Obesity is a major risk factor for the development of asthma, particularly for non-atopic asthma. Obesity is associated with changes in immune cell function and airway physiology, which likely lead to new onset disease in individuals without pre-existing asthma, and profoundly modify disease in those with pre-existing asthma.
References (43)
- et al.
The association between obesity and asthma is stronger in nonallergic than allergic adults
Chest
(2006) - et al.
Body mass index, asthma and allergic rhinoconjunctivitis in swedish conscripts-a national cohort study over three decades
Respir Med
(2005) - et al.
Obesity and asthma: a specific phenotype?
Chest
(2008) - et al.
Effect of leptin on allergic airway responses in mice
J Allergy Clin Immunol
(2005) - et al.
Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry
J Immunol Methods
(2007) - et al.
A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma
J Allergy Clin Immunol
(2011) - et al.
A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and jnk-dependent pathways
J Biol Chem
(2007) - et al.
Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies
Am J Respir Crit Care Med
(2007) - et al.
Prospective study of body mass index, weight change, and risk of adult-onset asthma in women
Arch Intern Med
(1999) - et al.
Incidence of asthma and net change in symptoms in relation to changes in obesity
Eur Respir J
(2006)
Association of overweight with asthma symptoms in Japanese school children
Pediatr Int
Relationship between obesity and asthma symptoms among children in ahvaz, iran: a cross sectional study
Ital J Pediatr
Obesity may increase the incidence of asthma in women but not in men: longitudinal observations from the canadian national population health surveys
Am J Epidemiol
Association of childhood obesity with atopic and nonatopic asthma: results from the national health and nutrition examination survey 1999–2006
J Asthma
Obesity, insulin resistance and the prevalence of atopy and asthma in us adults
Allergy
Atopy, obesity, and asthma in adults: the humboldt study
J Agromedicine
Association of obesity and insulin resistance with asthma and aeroallergen sensitization
Allergy
Eosinophils and asthma
Curr Allergy Asthma Rep
An official ats clinical practice guideline: Interpretation of exhaled nitric oxide levels (feno) for clinical applications
Am J Respir Crit Care Med
Airway inflammation in obese and nonobese patients with difficult-to-treat asthma
Allergy
Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics
Respir Res
Cited by (47)
Eosinophilic and noneosinophilic asthma: Beyond severe asthma
2023, Asthma in the 21st Century: New Research AdvancesTh1/Th2 cytokines profile in overweight/obese young adults and their correlation with airways inflammation
2022, Journal of Taibah University Medical SciencesCitation Excerpt :The concentration of several inflammatory cytokines has been reported to be positively correlated with BMI.7 In contrast, reducing body weight is associated with a reduction in the circulating inflammatory mediators.8 It is believed that this cytokines network has crucial participation in the pathogenesis of obesity and its related health complications.9
Long-term methylglyoxal intake aggravates murine Th2-mediated airway eosinophil infiltration
2020, International ImmunopharmacologyCitation Excerpt :Symptoms of asthma in obese individuals tend to be more severe, progressing toward a difficult-to-control phenotype. Accordingly, weight loss and remission of type 2 diabetes mellitus (T2DM) in obese individuals have been associated with improvements in the systemic and pulmonary inflammatory profiles of asthmatic patients [4–6]. It has been suggested that the presence of hyperglycemia and insulin resistance may be a potential link between obesity/T2DM and asthma [7,8].
Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO
2017, Annals of Allergy, Asthma and ImmunologyCitation Excerpt :Uncontrolled asthma has been noted to contribute to obesity owing to an increased use of corticosteroids55–57 or inactivity resulting from a substantial asthma symptom burden.58–60 A link between early- and late-onset allergic asthma and obesity has been described.61 The presence of allergen sensitization can increase health care resource use in adults and children62–65 and has been reported to increase the risk of exacerbations in adults.66
Prevalence, risk factors, and clinical outcomes of atopic and nonatopic asthma among rural children
2017, Annals of Allergy, Asthma and ImmunologyCitation Excerpt :Being overweight or obese increases the risk of asthma in nonatopic children.43,44 It has been suggested that these effects may be mediated through systemic inflammation, which may be a key factor in mediating the effects of overweight and/or obesity.45 In our study, the association between ex-smoking mothers and asthma but not current smoking mothers may reflect changes in smoking behavior of the mother after the diagnosis of asthma.
- ☆
Supported by NIH grants: P20 RR15557, RR019965, P30 GM 103532.